首页 > 最新文献

The European Journal of Health Economics最新文献

英文 中文
Projected costs of informal care for older people in England 英格兰老年人非正式护理的预计费用
Pub Date : 2023-12-12 DOI: 10.1007/s10198-023-01643-1
Bo Hu, Javiera Cartagena-Farias, Nicola Brimblecombe, Shari Jadoolal, Raphael Wittenberg

Background

Health economics research and economic evaluation have increasingly taken a societal perspective, accounting for the economic impacts of informal care. Projected economic costs of informal care help researchers and policymakers understand better the long-term consequences of policy reforms and health interventions. This study makes projections of the economic costs of informal care for older people in England.

Methods

Data come from two national surveys: the English Longitudinal Study of Ageing (ELSA, N = 35,425) and the Health Survey for England (N = 17,292). We combine a Markov model with a macrosimulation model to make the projections. We explore a range of assumptions about future demographic and epidemiological trends to capture model uncertainty and take a Bayesian approach to capture parameter uncertainty.

Results

We estimate that the economic costs of informal care were £54.2 billion in 2019, three times larger than the expenditure on formal long-term care. Those costs are projected to rise by 87% by 2039, faster than public expenditure but slower than private expenditure on formal long-term care. These results are sensitive to assumptions about future life expectancy, fertility rates, and progression of disabilities in the population.

Conclusions

Prevention schemes aiming to promote healthy aging and independence will be important to alleviate the costs of informal care. The government should strengthen support for informal caregivers and care recipients to ensure the adequacy of care, protect the well-being of caregivers, and prevent the costs of informal care from spilling over to other sectors of the economy.

背景卫生经济学研究和经济评估越来越多地从社会角度出发,考虑非正规护理的经济影响。预测非正规护理的经济成本有助于研究人员和政策制定者更好地理解政策改革和健康干预措施的长期后果。本研究对英格兰老年人非正式照护的经济成本进行了预测。方法数据来自两项全国性调查:英格兰老龄化纵向研究(ELSA,N = 35425)和英格兰健康调查(N = 17292)。我们结合马尔可夫模型和宏观模拟模型进行预测。我们探讨了一系列有关未来人口和流行病趋势的假设,以捕捉模型的不确定性,并采用贝叶斯方法捕捉参数的不确定性。结果我们估计,2019 年非正规护理的经济成本为 542 亿英镑,是正规长期护理支出的三倍。预计到 2039 年,这些成本将增长 87%,增长速度高于公共支出,但低于正规长期护理的私人支出。这些结果对有关未来预期寿命、生育率和人口残疾进展的假设非常敏感。结论旨在促进健康老龄化和独立性的预防计划对于减轻非正规护理成本非常重要。政府应加强对非正规护理人员和护理对象的支持,以确保护理的充分性,保护护理人员的福利,并防止非正规护理的成本蔓延到其他经济部门。
{"title":"Projected costs of informal care for older people in England","authors":"Bo Hu, Javiera Cartagena-Farias, Nicola Brimblecombe, Shari Jadoolal, Raphael Wittenberg","doi":"10.1007/s10198-023-01643-1","DOIUrl":"https://doi.org/10.1007/s10198-023-01643-1","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Health economics research and economic evaluation have increasingly taken a societal perspective, accounting for the economic impacts of informal care. Projected economic costs of informal care help researchers and policymakers understand better the long-term consequences of policy reforms and health interventions. This study makes projections of the economic costs of informal care for older people in England.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Data come from two national surveys: the English Longitudinal Study of Ageing (ELSA, <i>N</i> = 35,425) and the Health Survey for England (<i>N</i> = 17,292). We combine a Markov model with a macrosimulation model to make the projections. We explore a range of assumptions about future demographic and epidemiological trends to capture model uncertainty and take a Bayesian approach to capture parameter uncertainty.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>We estimate that the economic costs of informal care were £54.2 billion in 2019, three times larger than the expenditure on formal long-term care. Those costs are projected to rise by 87% by 2039, faster than public expenditure but slower than private expenditure on formal long-term care. These results are sensitive to assumptions about future life expectancy, fertility rates, and progression of disabilities in the population.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Prevention schemes aiming to promote healthy aging and independence will be important to alleviate the costs of informal care. The government should strengthen support for informal caregivers and care recipients to ensure the adequacy of care, protect the well-being of caregivers, and prevent the costs of informal care from spilling over to other sectors of the economy.</p>","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138575357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-reported experience is associated with higher future revenue and lower costs of hospitals 患者报告的经验与医院未来收入增加和成本降低有关
Pub Date : 2023-12-09 DOI: 10.1007/s10198-023-01646-y
Alice Giese, Rasheda Khanam, Son Nghiem, Thomas Rosemann, Michael M. Havranek

Background

Despite the established positive association between patient experience and patient volume, the relationship between patient experience and the financial performance of hospitals has not been studied thoroughly.

Methods

To investigate this relationship, we used longitudinal data from 132 Swiss acute-care hospitals from 2016 to 2019 to examine the associations between patient experience and the proportion of elective patients, revenue, costs, and profits of hospitals. To account for a potential time lag effect, we utilized annual patient experience data and employed multilevel mixed-effects regression modeling to investigate its association with the aforementioned financial performance indicators for the following year.

Results

Data for private and public hospitals were analyzed both separately and in combination, to account for the different proportions of elective patients in these types of hospitals. The resulting mixed models, revealed that for each year studied, the previous year’s patient experience was positively associated with the current year’s proportion of elective patients (β = 0.09, p = 0.004, all hospitals) and revenue (β = 1789.83, p = 0.037, private hospitals only), and negatively associated with costs (β = − 1191.13, p = 0.017, all hospitals); but not significantly associated with future profits (β = 629.12, p = 0.240, all hospitals).

Conclusions

This analysis showed that better patient experience is associated with a higher proportion of elective patients, greater revenue, and lower costs. Our findings may assist hospital managers and regulators in identifying strategies to increase revenue and reduce costs.

背景尽管患者体验与患者数量之间存在既定的正相关关系,但患者体验与医院财务绩效之间的关系尚未得到深入研究。方法为了研究这种关系,我们使用了 132 家瑞士急症护理医院 2016 年至 2019 年的纵向数据,研究了患者体验与医院的择期患者比例、收入、成本和利润之间的关系。为了考虑潜在的时滞效应,我们利用年度患者体验数据,并采用多层次混合效应回归模型来研究其与次年上述财务绩效指标之间的关联。结果 对私立医院和公立医院的数据进行了单独分析和组合分析,以考虑到这些类型医院中择期就诊患者比例的不同。混合模型显示,在研究的每一年中,上一年的患者体验与当年的择期患者比例(β = 0.09,p = 0.004,所有医院)和收入(β = 1789.83,p = 0.037,仅私立医院)呈正相关,而与成本(β = - 1191.结论这项分析表明,更好的患者体验与更高的择期患者比例、更高的收入和更低的成本相关。我们的研究结果可能有助于医院管理者和监管者确定增加收入和降低成本的策略。
{"title":"Patient-reported experience is associated with higher future revenue and lower costs of hospitals","authors":"Alice Giese, Rasheda Khanam, Son Nghiem, Thomas Rosemann, Michael M. Havranek","doi":"10.1007/s10198-023-01646-y","DOIUrl":"https://doi.org/10.1007/s10198-023-01646-y","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Despite the established positive association between patient experience and patient volume, the relationship between patient experience and the financial performance of hospitals has not been studied thoroughly.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>To investigate this relationship, we used longitudinal data from 132 Swiss acute-care hospitals from 2016 to 2019 to examine the associations between patient experience and the proportion of elective patients, revenue, costs, and profits of hospitals. To account for a potential time lag effect, we utilized annual patient experience data and employed multilevel mixed-effects regression modeling to investigate its association with the aforementioned financial performance indicators for the following year.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Data for private and public hospitals were analyzed both separately and in combination, to account for the different proportions of elective patients in these types of hospitals. The resulting mixed models, revealed that for each year studied, the previous year’s patient experience was positively associated with the current year’s proportion of elective patients (β = 0.09, <i>p</i> = 0.004, all hospitals) and revenue (β = 1789.83, <i>p</i> = 0.037, private hospitals only), and negatively associated with costs (β = − 1191.13, <i>p</i> = 0.017, all hospitals); but not significantly associated with future profits (β = 629.12, <i>p</i> = 0.240, all hospitals).</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>This analysis showed that better patient experience is associated with a higher proportion of elective patients, greater revenue, and lower costs. Our findings may assist hospital managers and regulators in identifying strategies to increase revenue and reduce costs.</p>","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138559759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to comment on “Demonstrating the value of cancer biomarkers at the population” 回复关于“展示癌症生物标志物在人群中的价值”的评论
Pub Date : 2022-05-13 DOI: 10.1007/s10198-022-01475-5
Ana Beatriz D’Avó Luís, Mikyung Kelly Seo
{"title":"Reply to comment on “Demonstrating the value of cancer biomarkers at the population”","authors":"Ana Beatriz D’Avó Luís, Mikyung Kelly Seo","doi":"10.1007/s10198-022-01475-5","DOIUrl":"https://doi.org/10.1007/s10198-022-01475-5","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86470984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demonstrating the value of cancer biomarkers at the population level 证明癌症生物标志物在人群水平上的价值
Pub Date : 2022-05-13 DOI: 10.1007/s10198-022-01474-6
A. Gandjour
{"title":"Demonstrating the value of cancer biomarkers at the population level","authors":"A. Gandjour","doi":"10.1007/s10198-022-01474-6","DOIUrl":"https://doi.org/10.1007/s10198-022-01474-6","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81410179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European union regulation of health technology assessment: what is required for it to succeed? 欧盟卫生技术评估法规:要取得成功需要什么?
Pub Date : 2022-03-29 DOI: 10.1007/s10198-022-01458-6
M. Drummond, R. Tarricone, A. Torbica
{"title":"European union regulation of health technology assessment: what is required for it to succeed?","authors":"M. Drummond, R. Tarricone, A. Torbica","doi":"10.1007/s10198-022-01458-6","DOIUrl":"https://doi.org/10.1007/s10198-022-01458-6","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81329075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Seeking efficiency gains outside drugs and diagnostics 寻求药物和诊断之外的效率提升
Pub Date : 2022-03-19 DOI: 10.1007/s10198-022-01456-8
Reyes Lorente, F. Antoñanzas
{"title":"Seeking efficiency gains outside drugs and diagnostics","authors":"Reyes Lorente, F. Antoñanzas","doi":"10.1007/s10198-022-01456-8","DOIUrl":"https://doi.org/10.1007/s10198-022-01456-8","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87450601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The attractiveness of jobs in the German care sector: results of a factorial survey 德国护理行业工作的吸引力:析因调查的结果
Pub Date : 2022-03-18 DOI: 10.1007/s10198-022-01443-z
Martin Kroczek, Jochen Andreas Späth
{"title":"The attractiveness of jobs in the German care sector: results of a factorial survey","authors":"Martin Kroczek, Jochen Andreas Späth","doi":"10.1007/s10198-022-01443-z","DOIUrl":"https://doi.org/10.1007/s10198-022-01443-z","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78061633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Looking into the black box of “Medical Innovation”: rising health expenditures by illness type 透视“医疗创新”黑箱:按病种分类的医疗支出上升
Pub Date : 2022-03-17 DOI: 10.1007/s10198-022-01447-9
F. Breyer, Normann Lorenz, G. Pruckner, T. Schober
{"title":"Looking into the black box of “Medical Innovation”: rising health expenditures by illness type","authors":"F. Breyer, Normann Lorenz, G. Pruckner, T. Schober","doi":"10.1007/s10198-022-01447-9","DOIUrl":"https://doi.org/10.1007/s10198-022-01447-9","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87061743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots 长期以来卫生经济评价准则官方贴现率的全面审查:趋势和根源
Pub Date : 2022-03-02 DOI: 10.1007/s10198-022-01445-x
E. Khorasani, M. Davari, A. Kebriaeezadeh, Farshad Fatemi, A. Akbari Sari, V. Varahrami
{"title":"A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots","authors":"E. Khorasani, M. Davari, A. Kebriaeezadeh, Farshad Fatemi, A. Akbari Sari, V. Varahrami","doi":"10.1007/s10198-022-01445-x","DOIUrl":"https://doi.org/10.1007/s10198-022-01445-x","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87897281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database 从与诊断相关的组中得出的成本是否适合用于经济评价?欧洲医疗保健和社会成本数据库中9个欧洲国家的比较
Pub Date : 2022-02-26 DOI: 10.1007/s10198-022-01444-y
Z. Špacírová, D. Epstein, J. Espín
{"title":"Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database","authors":"Z. Špacírová, D. Epstein, J. Espín","doi":"10.1007/s10198-022-01444-y","DOIUrl":"https://doi.org/10.1007/s10198-022-01444-y","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89496079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
The European Journal of Health Economics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1